Ignite Creation Date:
2025-12-24 @ 7:38 PM
Ignite Modification Date:
2026-01-26 @ 5:02 AM
Study NCT ID:
NCT06850103
Status:
RECRUITING
Last Update Posted:
2025-12-01
First Post:
2025-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
Sponsor:
First Affiliated Hospital of Zhejiang University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SCRT-CAP-Serp TriFire
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None